Evoke Pharma Inc • EVOK

Capital at risk.

About Evoke Pharma Inc
Ticker
info
EVOK
Trading on
info
NASDAQ
ISIN
info
US30049G2030
Industry
info
Drug Manufacturers - Specialty & Generic
Sector
info
Healthcare
CEO
info
-
Headquarters
info
420 Stevens Avenue, Solana Beach, CA, United States, 92075
Employees
info
3
Website
info
evokepharma.com
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California. As of December 15, 2025, Evoke Pharma, Inc. operates as a subsidiary of QOL Medical, LLC.
Metrics
BasicAdvanced
Market cap
info
$18.9M
P/E ratio
info
-
EPS
info
-$1.38
Dividend Yield
info
0.00%
Beta
info
-0.14
Forward P/E ratio
info
0
EBIDTA
info
-
Ex dividend date
info
-
Price & volume
Market cap
info
$18.9M
Average daily volume
info
-
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-0.1
Trailing P/E
info
0
Price to sales
info
1.31
Price to book
info
5.64
Earnings
EPS
info
-$1.38
EPS estimate (current quarter)
info
-$0.45
EPS estimate (next quarter)
info
-$0.30
EBITDA
info
-
Revenues (TTM)
info
$14.4M
Revenues per share (TTM)
info
$5.18
Technicals
Beta
info
-0.14
52-week High
info
$10.95
52-week Low
info
$1.94
50-day moving average
info
$8.64
200-day moving average
info
$5.06
Short ratio
info
0.03
Short %
info
0.45%
Management effectiveness
ROE (TTM)
info
-134.88%
ROA (TTM)
info
-21.78%
Profit margin
info
-36.23%
Gross profit margin
info
$14M
Operating margin
info
-26.56%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
61.40%
Share stats
Outstanding Shares
info
1.7M
Float
info
1.4M
Insiders %
info
10.62%
Institutions %
info
25.05%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$18.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.77
-$0.63
-22.22%
Q4 • 24Missed
-$0.51
-$0.33
-54.55%
Q1 • 25Missed
-$0.62
-$0.30
-106.67%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$3.8M
$-1.6M
-41.87%
Q2 • 25
$4.3M
$-1.2M
-26.99%
Q3 • 25
14.17%
-26.40%
-35.54%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$16.1M
$11.7M
72.76%
Q2 • 25
$15.6M
$12.3M
78.52%
Q3 • 25
-2.56%
5.15%
7.91%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-0.6M
-
$0M
$-0.6M
Q2 • 25
$-0.5M
-
$0M
$-0.5M
Q3 • 25
-7.62%
-
∞%
-7.62%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Evoke Pharma Inc share?
Collapse

Evoke Pharma Inc shares are currently traded for undefined per share.

How many shares does Evoke Pharma Inc have?
Collapse

Evoke Pharma Inc currently has 1.7M shares.

Does Evoke Pharma Inc pay dividends?
Collapse

No, Evoke Pharma Inc doesn't pay dividends.

What is Evoke Pharma Inc 52 week high?
Collapse

Evoke Pharma Inc 52 week high is $10.95.

What is Evoke Pharma Inc 52 week low?
Collapse

Evoke Pharma Inc 52 week low is $1.94.

What is the 200-day moving average of Evoke Pharma Inc?
Collapse

Evoke Pharma Inc 200-day moving average is $5.06.

Who is Evoke Pharma Inc CEO?
Collapse

The CEO of Evoke Pharma Inc is -.

How many employees Evoke Pharma Inc has?
Collapse

Evoke Pharma Inc has 3 employees.

What is the market cap of Evoke Pharma Inc?
Collapse

The market cap of Evoke Pharma Inc is $18.9M.

What is the P/E of Evoke Pharma Inc?
Collapse

The current P/E of Evoke Pharma Inc is null.

What is the EPS of Evoke Pharma Inc?
Collapse

The EPS of Evoke Pharma Inc is -$1.38.

What is the PEG Ratio of Evoke Pharma Inc?
Collapse

The PEG Ratio of Evoke Pharma Inc is -0.1.

What do analysts say about Evoke Pharma Inc?
Collapse

According to the analysts Evoke Pharma Inc is considered a buy.